FDA inspection
Geri-Care Pharmaceuticals Corp.: FDA inspection ending Aug 13, 2002
FDA inspection 229821 · Voluntary Action Indicated (VAI) · Brooklyn, NY
Key facts
| Inspection ID | 229821 |
|---|---|
| Firm | Geri-Care Pharmaceuticals Corp. |
| FEI number | 2435388 |
| Address | 1650 63rd St |
| City | Brooklyn |
| State | NY |
| ZIP | 11204-2713 |
| Fiscal year | 2002 |
| Inspection end date | Aug 13, 2002 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data